Ottawa announces MaRS Innovation partnership
MaRS Innovation — a commercialization partnership of 14 Toronto-based academic research institutions — is among 11 new Centres of Excellence for Commercialization and Research (CECRs) announced last week in Ottawa.
As a CECR, MaRS Innovation will receive $14.95 million for a five-year program to accelerate the commercialization of promising research from its member institutions. The Founding Board Chair of MaRS Innovation is Mary Jo Haddad, President and CEO of The Hospital for Sick Children.
More information:
- CECR news release: “Government of Canada announces 11 new Centres of Excellence for Commercialization and Research”
- MaRS news relase: “Ottawa Funds MaRS Innovation”
Linda Quattrin worked as a long-time newspaper reporter and editor before applying her interest in science as a medical research communicator. A member of the Canadian Science Writers Association, she is responsible for media relations and corporate communications at MaRS.